These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 15665549

  • 1. Comparison of the effect of pentoxifylline and captopril on proteinuria in patients with type 2 diabetes mellitus.
    Aminorroaya A, Janghorbani M, Rezvanian H, Aminian T, Gharavi M, Amini M.
    Nephron Clin Pract; 2005; 99(3):c73-7. PubMed ID: 15665549
    [Abstract] [Full Text] [Related]

  • 2. Captopril and combination therapy of captopril and pentoxifylline in reducing proteinuria in diabetic nephropathy.
    Roozbeh J, Banihashemi MA, Ghezlou M, Afshariani R, Salari S, Moini M, Sagheb MM.
    Ren Fail; 2010 Jan; 32(2):172-8. PubMed ID: 20199178
    [Abstract] [Full Text] [Related]

  • 3. The effect of pentoxifylline on reduction of proteinuria among patients with type 2 diabetes under blockade of angiotensin system: a double blind and randomized clinical trial.
    Ghorbani A, Omidvar B, Beladi-Mousavi SS, Lak E, Vaziri S.
    Nefrologia; 2012 Jan; 32(6):790-6. PubMed ID: 23169362
    [Abstract] [Full Text] [Related]

  • 4. Additive antiproteinuric effect of pentoxifylline in patients with type 2 diabetes under angiotensin II receptor blockade: a short-term, randomized, controlled trial.
    Navarro JF, Mora C, Muros M, García J.
    J Am Soc Nephrol; 2005 Jul; 16(7):2119-26. PubMed ID: 15917336
    [Abstract] [Full Text] [Related]

  • 5. [Lack of effect of ACE inhibition on severe proteinuria in diabetic nephropathy--a 6-month-long study].
    Hay U, Ludvik B, Gisinger C, Schernthaner G.
    Schweiz Med Wochenschr; 1988 Feb 06; 118(5):165-9. PubMed ID: 3278375
    [Abstract] [Full Text] [Related]

  • 6. Long term follow-up of the effect of captopril on severe proteinuria in hypertensive diabetic patients.
    Romero R, Salinas I, Teixidó J, Lucas A, Felip A, Sanmarti A.
    J Hum Hypertens; 1990 Dec 06; 4(6):671-5. PubMed ID: 2096209
    [Abstract] [Full Text] [Related]

  • 7. Pentoxifylline reduces proteinuria in insulin-dependent and non insulin-dependent diabetic patients.
    Guerrero-Romero F, Rodríguez-Morán M, Paniagua-Sierra JR, García-Bulnes G, Salas-Ramírez M, Amato D.
    Clin Nephrol; 1995 Feb 06; 43(2):116-21. PubMed ID: 7736673
    [Abstract] [Full Text] [Related]

  • 8. Will the addition of pentoxifylline reduce proteinuria in patients with diabetic glomerulosclerosis refractory to maximal doses of both an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker?
    Diskin CJ, Stokes TJ, Dansby LM, Radcliff L, Carter TB.
    J Nephrol; 2007 Feb 06; 20(4):410-6. PubMed ID: 17879206
    [Abstract] [Full Text] [Related]

  • 9. Effect of captopril on heavy proteinuria in azotemic diabetics.
    Taguma Y, Kitamoto Y, Futaki G, Ueda H, Monma H, Ishizaki M, Takahashi H, Sekino H, Sasaki Y.
    N Engl J Med; 1985 Dec 26; 313(26):1617-20. PubMed ID: 3906398
    [Abstract] [Full Text] [Related]

  • 10. [The effect of blood pressure-reducing therapy with captopril on tubular marker excretion in type-1 diabetics with nephropathy].
    Ratzmann KP, Raskovic M, Schimke E.
    Dtsch Med Wochenschr; 1994 Jun 03; 119(22):796-800. PubMed ID: 8205941
    [Abstract] [Full Text] [Related]

  • 11. [Clinical state of a patient with nephrotic proteinuria successfully treated with combined therapy with angiotensin II receptor antagonists and angiotensin II converting enzyme inhibitors and pentoxifylline].
    Renke M, Rutkowski P, Tylicki L, Zietkiewicz M, Larczyński W, Rutkowski B.
    Przegl Lek; 2008 Jun 03; 65(6):312-4. PubMed ID: 18853664
    [Abstract] [Full Text] [Related]

  • 12. Effect of ACE inhibition by benazepril, enalapril and captopril on chronic and post exercise proteinuria.
    Székács B, Vajo Z, Dachman W.
    Acta Physiol Hung; 1996 Jun 03; 84(4):361-7. PubMed ID: 9328608
    [Abstract] [Full Text] [Related]

  • 13. Effect of long-term therapy with captopril on proteinuria and renal function in patients with non-insulin-dependent diabetes and with non-diabetic renal diseases.
    Liou HH, Huang TP, Campese VM.
    Nephron; 1995 Jun 03; 69(1):41-8. PubMed ID: 7891796
    [Abstract] [Full Text] [Related]

  • 14. [The effect of angiotensin-converting enzyme inhibitors on proteinuria in chronic glomerulonephritis].
    Erley CM, Komini E, Nicaeus T, Braun N, Wolf S, Risler T.
    Dtsch Med Wochenschr; 1994 Jan 28; 119(4):89-95. PubMed ID: 8299527
    [Abstract] [Full Text] [Related]

  • 15. Effect of pentoxifylline on proteinuria, markers of tubular injury and oxidative stress in non-diabetic patients with chronic kidney disease - placebo controlled, randomized, cross-over study.
    Renke M, Tylicki L, Rutkowski P, Knap N, Zietkiewicz M, Neuwelt A, Aleksandrowicz E, Łysiak-Szydłowska W, Woźniak M, Rutkowski B.
    Acta Biochim Pol; 2010 Jan 28; 57(1):119-23. PubMed ID: 20309434
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin receptor blocker and N-acetyl cysteine for reduction of proteinuria in patients with type 2 diabetes mellitus.
    Rasi Hashemi S, Noshad H, Tabrizi A, Mobasseri M, Tayebi Khosroshahi H, Heydarnejad M, Khalaj MR, Aghamohammadzadeh N.
    Iran J Kidney Dis; 2012 Jan 28; 6(1):39-43. PubMed ID: 22218118
    [Abstract] [Full Text] [Related]

  • 17. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy.
    Katavetin P, Eiam-Ong S, Suwanwalaikorn S.
    J Med Assoc Thai; 2006 Feb 28; 89(2):170-7. PubMed ID: 16579002
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of role of doxycycline (a matrix metalloproteinase inhibitor) on renal functions in patients of diabetic nephropathy.
    Aggarwal HK, Jain D, Talapatra P, Yadav RK, Gupta T, Kathuria KL.
    Ren Fail; 2010 Feb 28; 32(8):941-6. PubMed ID: 20722561
    [Abstract] [Full Text] [Related]

  • 19. Longitudinal evaluation of renal function in non-insulin-dependent diabetic patients with early nephropathy: effects of angiotensin-converting enzyme inhibition.
    Vora JP, Leese GP, Peters JR, Owens DR.
    J Diabetes Complications; 1996 Feb 28; 10(2):88-93. PubMed ID: 8777336
    [Abstract] [Full Text] [Related]

  • 20. Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial.
    Lin SL, Chen YM, Chiang WC, Wu KD, Tsai TJ.
    Am J Kidney Dis; 2008 Sep 28; 52(3):464-74. PubMed ID: 18617301
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.